870 related articles for article (PubMed ID: 33352473)
1. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Bräuner EV; Hickey M
Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
[TBL] [Abstract][Full Text] [Related]
2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
3. The association between
Bräuner EV; Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Hickey M
Compr Psychoneuroendocrinol; 2021 Feb; 5():100026. PubMed ID: 35754448
[TBL] [Abstract][Full Text] [Related]
4. The association between in-utero exposure to stressful life events during pregnancy and male reproductive function in a cohort of 20-year-old offspring: The Raine Study.
Bräuner EV; Hansen ÅM; Doherty DA; Dickinson JE; Handelsman DJ; Hickey M; Skakkebæk NE; Juul A; Hart R
Hum Reprod; 2019 Jul; 34(7):1345-1355. PubMed ID: 31143949
[TBL] [Abstract][Full Text] [Related]
5. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study.
Hickey M; Sloboda DM; Atkinson HC; Doherty DA; Franks S; Norman RJ; Newnham JP; Hart R
J Clin Endocrinol Metab; 2009 Oct; 94(10):3714-20. PubMed ID: 19567524
[TBL] [Abstract][Full Text] [Related]
6. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
Skiba MA; Bell RJ; Herbert D; Garcia AM; Islam RM; Davis SR
Hum Reprod; 2021 May; 36(6):1611-1620. PubMed ID: 33846715
[TBL] [Abstract][Full Text] [Related]
7. Prenatal exposure to maternal stressful life events and earlier age at menarche: the Raine Study.
Bräuner EV; Koch T; Juul A; Doherty DA; Hart R; Hickey M
Hum Reprod; 2021 Jun; 36(7):1959-1969. PubMed ID: 33744952
[TBL] [Abstract][Full Text] [Related]
8. Effect of the presence of polycystic ovary syndrome-related features on anti-Mullerian hormone and androstenedione levels in adolescents with or without menstrual irregularity.
Hanedan N; Ersoy B; Hanedan C; Ozyurt BC; Taneli F
Arch Gynecol Obstet; 2022 Aug; 306(2):523-531. PubMed ID: 35355114
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology.
Vural F; Vural B; Kardaş E; Ertürk Coşkun AD; Yildirim İ
Arch Gynecol Obstet; 2023 Apr; 307(4):1083-1090. PubMed ID: 36565362
[TBL] [Abstract][Full Text] [Related]
10. Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis.
Hickey M; Doherty DA; Atkinson H; Sloboda DM; Franks S; Norman RJ; Hart R
Hum Reprod; 2011 Jun; 26(6):1469-77. PubMed ID: 21478180
[TBL] [Abstract][Full Text] [Related]
11. Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents.
Villarroel C; López P; Merino PM; Iñiguez G; Sir-Petermann T; Codner E
Gynecol Endocrinol; 2015; 31(8):625-9. PubMed ID: 26190534
[TBL] [Abstract][Full Text] [Related]
12. Sex-dependent associations between maternal prenatal stressful life events, BMI trajectories and obesity risk in offspring: The Raine Study.
Bräuner EV; Lim YH; Koch T; Mori TA; Beilin L; Doherty DA; Juul A; Hart R; Hickey M
Compr Psychoneuroendocrinol; 2021 Aug; 7():100066. PubMed ID: 35757055
[TBL] [Abstract][Full Text] [Related]
13. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L
Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801
[TBL] [Abstract][Full Text] [Related]
14. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
Adams JM; Taylor AE; Crowley WF; Hall JE
J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
[TBL] [Abstract][Full Text] [Related]
17. New Diagnostic Criteria of Polycystic Ovarian Morphology for Adolescents: Impact on Prevalence and Hormonal Profile.
Merino PM; Villarroel C; Jesam C; López P; Codner E
Horm Res Paediatr; 2017; 88(6):401-407. PubMed ID: 29049986
[TBL] [Abstract][Full Text] [Related]
18. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
[TBL] [Abstract][Full Text] [Related]
19. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
[TBL] [Abstract][Full Text] [Related]
20. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
